Clinical Trials

Showing trials with last updates posted in 2021.

NCT04001101 | WITHDRAWN | PHASE2
0 participants

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-30
Start Date:
2019-10-10
Completion:
2021-11-17
Conditions
  • Microsatellite Instability High
  • Mismatch Repair Deficiency
  • Colorectal Cancer
Interventions
  • COMBINATION_PRODUCT
  • DRUG
No Results Yet
NCT03519984 | TERMINATED | PHASE1
3 participants

EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-30
Start Date:
2018-05-09
Completion:
2020-11-24
Conditions
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Blasts 5 Percent or More of Bone Marrow Nucleated Cells
  • Myelodysplastic/Myeloproliferative Neoplasm
  • Philadelphia Chromosome Positive
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Secondary Acute Myeloid Leukemia
  • T Acute Lymphoblastic Leukemia
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page